Chilala C, Foster N, Bahukudumbi S, Mohamed M, Zary M, Kafie C
BMJ Glob Health. 2025; 10(2).
PMID: 39947715
PMC: 11831268.
DOI: 10.1136/bmjgh-2024-016535.
Kafie C, Mohamed M, Zary M, Chilala C, Bahukudumbi S, Gore G
BMJ Glob Health. 2024; 9(10).
PMID: 39477335
PMC: 11529515.
DOI: 10.1136/bmjgh-2024-015654.
Gwiasda M, Rathjens L, Martin D, Mohler R, Schwarz S, Jenetzky E
J Int Med Res. 2024; 52(9):3000605241274550.
PMID: 39253830
PMC: 11388306.
DOI: 10.1177/03000605241274550.
Gordon I, Odume B, Ogbudebe C, Chukwuogo O, Nwokoye N, Useni S
Public Health Action. 2024; 14(2):61-65.
PMID: 38957501
PMC: 11216288.
DOI: 10.5588/pha.24.0008.
Jallal M, Serhier Z, Berrami H, Bennani Othmani M
Cureus. 2024; 15(12):e50963.
PMID: 38259391
PMC: 10801268.
DOI: 10.7759/cureus.50963.
Barriers and facilitators of implementing electronic monitors to improve adherence and health outcomes in tuberculosis patients: protocol for a systematic review based on the Consolidated Framework for Implementation Research.
Li W, Su M, Zhang W, Fan X, Li R, Gao Y
Health Res Policy Syst. 2023; 21(1):115.
PMID: 37915089
PMC: 10621129.
DOI: 10.1186/s12961-023-01054-x.
Mapping the effectiveness of the community tuberculosis care programs: a systematic review.
Sejie G, Mahomed O
Syst Rev. 2023; 12(1):135.
PMID: 37537689
PMC: 10399107.
DOI: 10.1186/s13643-023-02296-0.
Effect of mobile health reminders on tuberculosis treatment outcomes in Shanghai, China: A prospective cohort study.
Wu Z, Lu L, Li Y, Chen J, Zhang Z, Ning C
Front Public Health. 2023; 11:923319.
PMID: 37181717
PMC: 10173861.
DOI: 10.3389/fpubh.2023.923319.
Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial.
Manyazewal T, Woldeamanuel Y, Getinet T, Hoover A, Bobosha K, Fuad O
EClinicalMedicine. 2023; 56:101820.
PMID: 36684395
PMC: 9853306.
DOI: 10.1016/j.eclinm.2022.101820.
Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial.
Manyazewal T, Woldeamanuel Y, Holland D, Fekadu A, Marconi V
BMC Med. 2022; 20(1):310.
PMID: 36167528
PMC: 9514884.
DOI: 10.1186/s12916-022-02521-y.
Effect of Digital Medication Event Reminder and Monitor-Observed Therapy vs Standard Directly Observed Therapy on Health-Related Quality of Life and Catastrophic Costs in Patients With Tuberculosis: A Secondary Analysis of a Randomized Clinical Trial.
Manyazewal T, Woldeamanuel Y, Fekadu A, Holland D, Marconi V
JAMA Netw Open. 2022; 5(9):e2230509.
PMID: 36107429
PMC: 9478770.
DOI: 10.1001/jamanetworkopen.2022.30509.
Cost-effectiveness of a medication event monitoring system for tuberculosis management in Morocco.
Yang J, Kim H, Park S, Sentissi I, Green N, Oh B
PLoS One. 2022; 17(4):e0267292.
PMID: 35439273
PMC: 9017941.
DOI: 10.1371/journal.pone.0267292.
Technologies for Medication Adherence Monitoring and Technology Assessment Criteria: Narrative Review.
Mason M, Cho Y, Rayo J, Gong Y, Harris M, Jiang Y
JMIR Mhealth Uhealth. 2022; 10(3):e35157.
PMID: 35266873
PMC: 8949687.
DOI: 10.2196/35157.
Adherence to Growth Hormone Treatment Using a Connected Device in Latin America: Real-World Exploratory Descriptive Analysis Study.
Assefi A, van Dommelen P, Arnaud L, Otero C, Fernandez-Luque L, Koledova E
JMIR Mhealth Uhealth. 2022; 10(1):e32626.
PMID: 35049518
PMC: 8814928.
DOI: 10.2196/32626.
A randomised controlled trial to evaluate a medication monitoring system for TB treatment.
Acosta J, Flores P, Alarcon M, Grande-Ortiz M, Moreno-Exebio L, Puyen Z
Int J Tuberc Lung Dis. 2021; 26(1):44-49.
PMID: 34969428
PMC: 8734191.
DOI: 10.5588/ijtld.21.0373.
Tuberculosis in the middle of COVID-19 in Morocco: efforts, challenges and recommendations.
Bouaddi O, Hasan M, Sahito A, Shah P, Mohammed A, Essar M
Trop Med Health. 2021; 49(1):98.
PMID: 34930506
PMC: 8685801.
DOI: 10.1186/s41182-021-00388-y.
Improving Treatment Adherence with Integrated Patient Management for TB Patients in Morocco.
Park S, Moon N, Oh B, Park M, Kang K, Sentissi I
Int J Environ Res Public Health. 2021; 18(19).
PMID: 34639291
PMC: 8507615.
DOI: 10.3390/ijerph18199991.
Directly Observed Therapy to Measure Adherence to Tuberculosis Medication in Observational Research: Protocol for a Prospective Cohort Study.
Ragan E, Gill C, Banos M, Bouton T, Rooney J, Horsburgh C
JMIR Res Protoc. 2021; 10(6):e24510.
PMID: 34132642
PMC: 8277341.
DOI: 10.2196/24510.
Effect of using electronic medication monitors on tuberculosis treatment outcomes in China: a longitudinal ecological study.
Wang N, Guo L, Shewade H, Thekkur P, Zhang H, Yuan Y
Infect Dis Poverty. 2021; 10(1):29.
PMID: 33731213
PMC: 7967105.
DOI: 10.1186/s40249-021-00818-3.
Do electronic medication monitors improve tuberculosis treatment outcomes? Programmatic experience from China.
Wang N, Shewade H, Thekkur P, Zhang H, Yuan Y, Wang X
PLoS One. 2020; 15(11):e0242112.
PMID: 33166361
PMC: 7652336.
DOI: 10.1371/journal.pone.0242112.